Look­ing to build in red-hot vi­ral vec­tor space, Ther­mo Fish­er inks $878M deal for Bel­gian man­u­fac­tur­er's 2 plants

Be­tween Covid-19 vac­cines and gene ther­a­pies, the con­tract man­u­fac­tur­ing mar­ket for vi­ral vec­tor tech has grown at a rapid clip. Ther­mo Fish­er Sci­en­tif­ic, al­ready one …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.